Clinical Trial Update: Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing doxorubicin with or without ifosfamide and pegfilgrastim for locally advanced or metastatic soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• IFOSFAMIDE (IFOSFAMIDE)
• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Sarcoma | Phase 3 | Status: COMPLETED